Care and treatment planning are organized according to multidisciplinary disease site groups (DSGS). There are 16 DSGs at CCMB, each with a team leader.
CCMB provides fully integrated benign hematology, medical/haematologic oncology, radiation oncology, pediatric oncology, gynecologic oncology and genitourinary oncology services. Surgical oncologists and other specialists also hold clinics within CCMB.
The Manitoba Blood and Marrow Transplant Program provides services for adult and pediatric patients with benign and malignant conditions through a partnership between CancerCare Manitoba and the Health Sciences Centre.
The Dr. Ernest W. Ramsey Manitoba Prostate Centre on the third floor of the MacCharles site is the provincial centre for diagnosis and treatment of both benign and malignant prostate disease. Other services include education, support services for patients and their families, and coordinating access to additional resources.
A program that seeks to improve patient care by promoting and supporting the shared care of the cancer patient is UPCON (Uniting Primary Care and Oncology). In its sixth year, UPCON provides cancer-related clinical support, educational events, and communication to primary care providers in the province. Future plans include full integration with the Community Cancer Program Network.
CCMB's MacCharles unit provides the only radiation treatment in the province but with the opening of the Western Manitoba Cancer Centre in Brandon - a joint venture of the Brandon Regional Health Authority and CancerCare Manitoba - radiation will become available in the southwestern part of the province. CCMB, in conjunction with the University of Winnipeg, is the home to the provincial School of Radiation Therapy.
The Division of Medical Physics at CancerCare Manitoba is unique in Canada in that it covers all aspects of cancer control and is responsible for all medical physics services throughout Manitoba: Radiation Protection, Therapeutic Radiation Physics, Diagnostic Physics, Radiation Protection, Medical Devices and Nuclear Electronics. There is an active Medical Physics Research program and the University of Manitoba's Graduate Program in Medical Physics is one of only five in Canada to have gained accreditation by the Commission on Accreditation of Medical Physics Educational Programs.
World class research is conducted at CCMB by medical staff and research scientists at the Research Institute of Oncology and Hematology (RIOH), a joint research institute of CancerCare Manitoba and the University of Manitoba, located at the MacCharles site. The Institute is dedicated to fundamental research in biology and its relation to health, with a primary emphasis on cancer and related diseases. RIOH's Translational Research Program enhances interaction and collaborative projects amongst clinicians, epidemiologists and scientists, expediting the application of research results into the clinical arena. RIOH plays a major role in training graduate and postgraduate students, medical trainees and investigators who come from around the world to work with the RIOH staff.
Clinical trial research involving both industry and cooperative group trials is offered for both adult and pediatric cancers and blood disorders through CancerCare Manitoba's Clinical Investigation Office. Clinical trials are available at the MacCharles and St. Boniface sites.
CCMB's Cancer Registry is one of the most robust registries in Canada and is tasked to collect, classify and maintain accurate comprehensive information on all cancer cases for the province of Manitoba. The Registry is the main source of data for CCMB's strong Epidemiology and Cancer Control Program. Analysis and population-based research undertaken by these programs informs CancerCare Manitoba's prevention, screening, and treatment efforts.
Provincial screening is currently provided for cervical, breast and colorectal cancer, the areas where scientific evidence suggests screening reduces cancer mortality.
CancerCare Manitoba's Patient and Family Support Services provide counseling, support groups, nutrition services and other resources such as the Guardian Angel Caring Room, CCMB's Breast Cancer Centre of Hope, and the Patient and Family Resource Centre.
The establishment of a Patient Navigation Program and Central Referral Office is helping to expedite and improve patients' transition through the cancer system from primary referral to final outcome. Work with Norway House Cree Nation and other partners seeks to accommodate the special concerns of First Nations, M������������������tis and Aboriginal populations in understanding and accessing cancer services.
All provincial budgets for intravenous oncology drugs have been consolidated at CCMB for centralized purchase, administration, and review under the Provincial Oncology Drug Program.